- Business Type:
- Manufacturer
- Year Established:
- 1992
- Total Revenue:
- Above US$100 Million
- Main Markets:
Company Description
Shineway produces products aiming at the segments of treatment of diseases commonly affecting middle and old aged people and/or children, and anti-viral treatment; and leverages the advantages of developing modern Chinese medicine of soft capsule, granule and injection dose forms. Shineway is the production base of the largest scale of the state-of-the-art technology producing soft capsule and injection of modern Chinese medicines. The company is manufacturing 9 dose forms of more than 200 items. Among all these, Wufu Xinnao Qing Soft Capsule, Qingkailing Soft Capsule, Liyan Jiedu Granule, Jieyu Anshen Granule, Nailibao Pill, etc., of almost 50 items are exporting to more than 10 foreign countries and regions globally.

